By contrast, the positive effect of PEK heterozygous mutant on OPMD muscle defects, associated with the decrease of eIF2α phosphorylation at later stages (day 6) is not consistent with a positive role of PEK through preventing translation. The gene discussed is EIF2AK3; the disease is oculopharyngeal muscular dystrophy.